Numis Securities Ltd reaffirmed their buy rating on shares of Emis Group Plc (LON:EMIS) in a report issued on Friday morning. Numis Securities Ltd currently has a GBX 1,150 ($14.85) target price on the stock.

Emis Group Plc (LON EMIS) opened at 917.50 on Friday. The stock has a 50 day moving average price of GBX 958.96 and a 200-day moving average price of GBX 925.93. Emis Group Plc has a 12-month low of GBX 786.97 and a 12-month high of GBX 1,027.00. The company’s market capitalization is GBX 576.61 million.

Emis Group Plc (LON:EMIS) last posted its quarterly earnings data on Thursday, August 31st. The company reported $0.13 EPS for the quarter. Emis Group Plc had a return on equity of 14.91% and a net margin of 10.88%. Equities analysts predict that Emis Group Plc will post $48.90 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This story was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another site, it was stolen and reposted in violation of United States and international trademark & copyright law. The original version of this story can be viewed at

The business also recently disclosed a dividend, which will be paid on Friday, October 27th. Stockholders of record on Thursday, September 21st will be paid a GBX 12.90 ($0.17) dividend. This represents a dividend yield of 1.42%. This is a positive change from Emis Group Plc’s previous dividend of $11.70. The ex-dividend date is Thursday, September 21st.

About Emis Group Plc

EMIS Group plc provides healthcare software, information technology and related services in the United Kingdom. The Company operates through three segments: Primary & Community Care; Community Pharmacy, and Secondary & Specialist Care. The Company serves various healthcare markets under the EMIS Health brand.

Receive News & Stock Ratings for Emis Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emis Group Plc and related stocks with our FREE daily email newsletter.